Traitement des cancers hématologiques

Le traitement des cancers hématologiques repose principalement sur la chimiothérapie, souvent associée à un traitement par anticorps monoclonaux (immunothérapie).

Selon les situations, le traitement peut faire appel à une radiothérapie ou à une greffe de cellules souches hématopoïétiques (greffe de moelle osseuse), réalisables à Gustave Roussy.

Treatment of haematological cancers

The Gustave Roussy Haematology Committee is responsible for management of patients with bone marrow and lymph node diseases (malignant blood diseases):

Molecular medicine

Molecular medicine – or personalised medicine, still called precision medicine, – is based on a new approach to diagnosis, known as molecular diagnosis, which depends on analysis of the tumour genome. According to the results of this analysis, targeted drugs tailored to the genetic profile are tried. The objective is to be able to offer each patient drugs which are specifically targeted to the genetic profile of the tumour.     

General Secretariat For Research

International Scientific Board

Gustave Roussy has renewed its Scientific Board in 2021, as well as the terms of its operation.

Request for a second medical opinion in gynaecology

Please visit our dedicated page for more information on Second Opinion requests.

University Faculty

Laurence ALBIGES
Full Professor, School of Medicine

Fabrice ANDRÉ
Full Professor, School of Medicine
Head of Research

Fabrice BARLESI
Full Professor, School of Medicine
Head of Gustave Roussy

Karim BENIHOUD
Full Professor, School of Sciences

Benjamin BESSE
Full Professor, School of Medicine

Pierre BLANCHARD
Full Professor, School of Medicine
Head of Gustave Roussy Education

Isabelle BORGET
Full Professor, School of Pharmacy